Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Ivax licenses cladribine for MS

Dec. 15, 2000

Centrally acting muscle relaxants acting via 5-HT receptors discovered at Eisai

Dec. 14, 2000

Vascular effects of first- and second-generation triptans compared in migraine patients

Dec. 14, 2000

Fujisawa announces Japanese launch of Myslee

Dec. 14, 2000

Aza compounds synthesized at Georgetown U. inhibit monoamine neurotransmitter reuptake

Dec. 13, 2000

Quinoxalinecarboxylic acid-based AMPA receptor antagonists with good solubility characteristics

Dec. 13, 2000

FDA clearance allows Amarin to begin Huntington's disease trials

Dec. 13, 2000

Novel catechol-based COMT inhibitors designed by Orion research group

Dec. 12, 2000

Acadia and Allergan discover novel treatment for chronic pain

Dec. 12, 2000

Lundbeck's insomnia drug enters phase II

Dec. 12, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....